View Document Preview and Link Open Document File Size: 1,48 MB Share Result on Facebook
City Asher / / Company AD / Atopic Dermatitis Worldwide / US Population Variable Age Subgroup / / Country Germany / United States / Italy / / Event FDA Phase / Product Issues / / Facility Green square / MTX Methotrexate NICE National Institute / National Institute / / IndustryTerm healthcare professionals / year age / microbial products / food allergens / food allergy / systemic products / / MedicalCondition increased bacterial and viral infections / allergic contact dermatitis / inflammatory skin response / Allergies / allergic diseases / atopic dermatitis/eczema / Atopic Dermatitis / bacterial and viral skin infections / disease / Background Materials BACKGROUND Atopic dermatitis / dermatitis / Severe Atopic Dermatitis / eczema / skin rash / chronic inflammatory skin disease / allergic disorders / barrier dysfunction / food allergy / local and systemic inflammatory responses / itchy rash / skin inflammation / environmental and infectious agents / allergic rhinitis / disorder / psoriasis / intractable pruritus / infectious agent / moderate-to-severe disease / pruritic inflammation / severe disease / inflammatory diseases / atopic eczema / systemic inflammatory responses / asthma / / MedicalTreatment Phototherapy / / Organization Care Excellence / Dermatologic and Ophthalmic Drugs Advisory Committee / Institution of Systemic Therapy / National Institute for Health and Care Excellence / Ophthalmic Drugs Advisory Committee Meeting Background Materials Meeting Package Dermatologic and Ophthalmic Drugs Advisory Committee / National Institute for Health / Specialized Term Explanation AAD American Academy of Dermatology AD Atopic / / Position Major / / Product Cyclosporine / prednisone / Azathioprine / innate immune responses / innate immune response / ISAAC / / SocialTag 
Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Background Materials Meeting Package Dermatologic and Ophthalmic Drugs Advisory Committee